维普期刊资源整合服务平台（V6.5）

83篇 您的检索式：作者名="Nimer SD"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma显示文摘	Kewalramani T Zelenetz AD Nimer SD	2004	Blood2004，103，10：	1
2	Efficacy of intensive chemotherapy for acute myelogenous leukemia associated with a preleukemic syndrome显示文摘	Gajewski JL Ho WG Nimer SD	1989	J Clin Oncol1989，7，11：	1
3	Myelodysplastic syndromes 显示文摘	Nimer SD	2008	Blood2008，111，0：	1
4	Effectiveness of high dose chemoradiotherapy and autologous stem cell transplantation for patients with biopsy-proven primary refractory Hodgkin disease显示文摘	Moskowitz CH Kewalramani T Nimer SD	2004	Br J Haemato12004，124，5：	1
5	Recombinant human erythropoietin and renal anemia:Molecular biology,clinical efficiency,and nervous system effects显示文摘	Nissenson AR Nimer SD Wolcott DL	1991	Ann Intern Med1991，114，：	1
6	2-step comprehensive high-dose chemoradiothcrapy second-line program for relapsed and re- fractory Hodgkin disease: Analysis by intent to treat and development of a prognostic model 显示文摘	Moskowitz CH Nimer SD Zelenetz AD	2001	Blood2001，97，3：	1
7	Myelodysplaztie syndromes 显示文摘	Nimer SD	2005	Blood2005，111，10：	1
8	Rituximab and DICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphomas显示文摘	Kewalramani T Zelenetz AD Nimer SD		0，，10：	1
9	Rituximab and ICE as second - line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B- cell lymphoma显示文摘	KewalramaniT ZelenetzAD Nimer SD	2004	Blood2004，103，10：	1
10	Myelodysplastic syndromes: diagnosis and staging显示文摘	Malcovati L Nimer SD	2008	Cancer Control2008，15，4：	1
11	Rituximab and ICE as second Line therapy before autologous stem cell transplantation for primary refrantory diffuse large B cell lymphoma显示文摘	Kewa Iramani T Zelenetz AD Nimer SD	2004	Blood2004，103，10：	1
12	Is it important to decipher the heterogeneity of 'nor?mal karyotype AML'?显示文摘	Nimer SD	2008	Best Pract Res Clin Haematol2008，21，：	1
13	Rituximab and ICEas second-line therapy before autologous stem cell transplantation forrelapsed or primary refractory diffuse large B-cell lymphoma显示文摘	Kewalramani T Zelenetz AD Nimer SD	2004	Blood2004，103，10：	1
14	Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma 显示文摘	Kewalramani T Zelenetz AD Nimer SD	2004	Blood2004，103，10：	1
15	An update on the molecular pathogenesis of myelodys- plastic syndromes显示文摘	Nimer SD	2011	Biol Blood Marrow Transplant2011，17，1：	1
16	Treatment of refractory aplastic anemia with recombinant human granulocyte-macrophagecolony-stimulating factor显示文摘	Champlin RE Nimer SD Ireland P	1989	Blood1989，，73：	1
17	Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B cell lymphoma显示文摘	Kewalramani T Zelenetz AD Nimer SD et a1	2008	Blood2008，103，10：	1
18	AML1-ETO driven acute leu- kemia: insights into pathogenesis and potential therapeutic ap- proaches显示文摘	Hatlen MA Wang L Nimer SD	2012	Front Med2012，6，3：	1
19	Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma 显示文摘	Kewalramani T Zelenetz AD Nimer SD	2004	Blood2004，103，10：	1
20	A 2 -step comprehensivehigh-dose chemoradiotherapy second-line program for relapsedof refractory Hodgkin disease, analysis by intent to treat anddevelopment of a prognostic modd显示文摘	Moskowitz CH Nimer SD Zelenetz AD	2001	Blood2001，97，3：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示